The article is devoted to debatable aspects of Helicobacter pylori eradication therapy. The eradication cancer-preventive effects are considered. A negative comorbidity between H. pylori infection and such diseases as gastroesophageal reflux disease, inflammatory bowel disease and bronchial asthma has been described. The perspectives of populational, individualized and personalized strategies for H. pylori eradication therapy assessment are given. Recommendations for individualized H. pylori eradication strategy implementation in practical healthcare are proposed.
机构:
China Med Univ, Affiliated Hosp 1, Dept Cadre Ward 5, Shenyang, Liaoning Provin, Peoples R ChinaChina Med Univ, Affiliated Hosp 1, Dept Cadre Ward 5, Shenyang, Liaoning Provin, Peoples R China
Dai, Cong
Zheng, Chang-Qing
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R ChinaChina Med Univ, Affiliated Hosp 1, Dept Cadre Ward 5, Shenyang, Liaoning Provin, Peoples R China
Zheng, Chang-Qing
Jiang, Min
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R ChinaChina Med Univ, Affiliated Hosp 1, Dept Cadre Ward 5, Shenyang, Liaoning Provin, Peoples R China